Brief: Adaptive Biotechnologies Q1 EPS USD -0.13
05/05/2026 21:05
May 05 (Reuters) - Adaptive Biotechnologies Q1 revenue USD 70.874 million vs. IBES estimate USD 60.9 million. Q1 net income USD -20.015 million Q1 operating income USD -19.206 million Q1 operating expenses USD 90.08 million Q1 adjusted EBITDA USD -2.5 million vs. IBES estimate USD -6.55 million
Recent news on Adaptive Biotechnologies
See all newsBrief: Adaptive Biotechnologies Corp - Issues $345 Million In 0% Convertible Senior Notes Due 2031 - SEC Filing
U.S. STOCKS ON THE MOVE-Jabil, BWX Technologies, Micron
U.S. STOCKS ON THE MOVE-Jabil, BWX Technologies, Micron
U.S. STOCKS ON THE MOVE-Intel, La-Z-Boy, CME
U.S. STOCKS ON THE MOVE-Intel, La-Z-Boy, AST SpaceMobile